Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor H Engelhard

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
The Journal of Clinical Investigation|February 27, 2018
Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapyYared Hailemichael, Amber Woods, Tihui Fu, et al.
Cancer Cell|May 10, 2022
An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomesAbhinav Jaiswal, Akanksha Verma, Ruth Dannenfelser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cellsCraig L Slingluff, Gina R Petroni, Galina V Yamshchikov, et al.
Journal for Immunotherapy of Cancer|May 10, 2020
MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanomaVictor H Engelhard, Rebecca C Obeng, Kara L Cummings, et al.
Science Translational Medicine|September 20, 2013
MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemiaMark Cobbold, Hugo De La Peña, Andrew Norris, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
The Journal of Clinical Investigation|February 27, 2018
Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapyYared Hailemichael, Amber Woods, Tihui Fu, et al.
Cancer Cell|May 10, 2022
An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomesAbhinav Jaiswal, Akanksha Verma, Ruth Dannenfelser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cellsCraig L Slingluff, Gina R Petroni, Galina V Yamshchikov, et al.
Journal for Immunotherapy of Cancer|May 10, 2020
MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanomaVictor H Engelhard, Rebecca C Obeng, Kara L Cummings, et al.
Science Translational Medicine|September 20, 2013
MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemiaMark Cobbold, Hugo De La Peña, Andrew Norris, et al.
Pageof 9